Latest News of IMTX
Immatics (IMTX): Short Seller Sentiment is Bearish On This ADR Stock
By Yahoo! Finance |
1 week ago
The article discusses the landscape of ADR stocks, focusing on Immatics (NASDAQ:IMTX), a German biopharmaceutical company specializing in cancer immunotherapy. Despite being shorted, the company shows...
Here's Why Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Is The Least Of Shareholders' Concerns
By Yahoo! Finance |
3 months ago
Immatics N.V.'s CEO, Harpreet Singh, has led the company well with a 49% EPS growth in the past three years. Shareholders will consider this performance when voting on executive compensation at the up...